Scoopfeeds — Intelligent news, curated.
Acadia Pharmaceuticals stock gets $23 price target from Oppenheimer on CHMP reversal
business

Acadia Pharmaceuticals stock gets $23 price target from Oppenheimer on CHMP reversal

Investing.com · Jun 26, 2026, 5:20 PM · Also reported by 2 other sources

Acadia Pharmaceuticals stock gets $23 price target from Oppenheimer on CHMP reversal

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop